Virion Therapeutics Company
Virion Therapeutics is a science-driven company developing innovative immune-based treatments for virally-associated cancers.
Investors
Industry:
Viral Vectors
Funding Status:
Early Stage Venture
Estimated Revenue:
Less than $1M
Investors Number:
7
Headquarters:
Newark, Delaware, United States
Total Funding:
14075858
Founded Date:
2018-01-01
Last Funding Type:
Debt Financing
Last Funding Date:
2020-08-24